Abstract
Since the onset of the COVID-19 pandemic, there have been rare reports of spinal cord pathology diagnosed as inflammatory myelopathy and suspected spinal cord ischemia after SARS-CoV-2 infection. Herein, we report five cases of clinical myelopathy and myeloradiculopathy in the setting of post-COVID-19 disease, which were all radiographically negative. Unlike prior reports which typically characterized hospitalized patients with severe COVID-19 disease and critical illness, these patients typically had asymptomatic or mild-moderate COVID-19 disease and lacked radiologic evidence of structural spinal cord abnormality. This case series highlights that COVID-19 associated myelopathy is not rare, requires a high degree of clinical suspicion as imaging markers may be negative, and raises several possible pathophysiologic mechanisms.
| Original language | English |
|---|---|
| Pages (from-to) | 650-655 |
| Number of pages | 6 |
| Journal | Journal of NeuroVirology |
| Volume | 27 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2021 |
Keywords
- Inflammatory myelopathy
- Ischemic myelopathy
- Long Haul Covid
- Post Acute Covid-19 Syndrome
- Transverse myelopathy syndrome
Fingerprint
Dive into the research topics of 'MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver